CVAC
CureVac NV
Price:  
3.59 
USD
Volume:  
526,952.00
Germany | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

CVAC Probability of Bankruptcy

The Probability of Bankruptcy of CureVac NV (CVAC) is -% . This number represents the probability that CVAC will face financial distress in the next 24 months given its current fundamentals and market conditions.

Multiple factors are taken into account when calculating CVAC's probability of bankruptcy : Altman Z-score, Beneish M-score, financial position, macro environments, academic research about distress risk and more.

CVAC - ESG ratings

ESG ratings are directly linked to the cost of capital and CVAC's ability to raise funding, both of which can significantly affect the probability of CureVac NV going bankrupt.

ESG Score 27.16
Environment Score 27.49
Social Score 40.97
Governance Score 13.02
Returns
Historical Returns (5 day) 0.84%
Historical Returns (MTD) 1.13%
Historical Returns (YTD) 5.28%
Historical Returns (13 week) -4.77%
Historical Returns (26 week) 28.21%
Historical Returns (52 week) 20.07%
Efficiency
Asset Turnover 0.74
Receiveable Turnover 31.55
Gross Margin 80.23%
Operating Margin 33.20%
Pretax Margin 35.67%
Net Margin 30.31%
Return on Asset (ROA) 22.34
Return on Equity (ROE) 28.90
Return on Investments (ROI) 26.99
Price Metrics
Market Cap (M) 808.32
Enterprise Value (M)
52 Week High 5.28
52 Week Low 2.37
Beta 2.50
Average Volume (10 day) 0.59
Average Volume (3 month) 0.76
Price / Earnings (P/E) 5.02
Price / Sales (P/S) 1.52
Earnings
EPS 0.72
Revenue CAGR (5 year) 98.42%
Risk
Current Ratio 7.28
Quick Ratio 7.04